Tolcapone is a medication used in the management and treatment of Parkinson disease. It is in the catechol-O-methyl transferase inhibitor class of drugs. This activity reviews the indications, action, and contraindications for tolcapone as a valuable agent in the management of Parkinson disease. This activity will highlight the mechanism of action, adverse event profile, off-label uses, and monitoring that is pertinent for members of the interprofessional team in the care of patients with Parkinson disease and related conditions.

**Objectives:**
- Identify the mechanism of action of tolcapone.
- Describe the potential adverse effects of tolcapone.
- Review the appropriate monitoring for tolcapone.
- Summarize some interprofessional team strategies for improving care coordination and communication to advance the management of Parkinson's disease using tolcapone and improve outcomes.